dual glp 1 glucagon receptor agonists LY3437943, a novel triple glucagon, GIP, and GLP-1 agonist for glycemic control and weight loss: From discovery to clinical proof of concept: Cell Metabolism Dual GLP-1/GIP receptor agonists mechanism
Description
Drawing from common best practices, the experience should feel reliable, evenly paced, and designed with clarity in mind
This is not the medication failing
Long-acting GLP-1RAs also have other benefits including improved gastrointestinal tolerability, moderate plasma drug concentration fluctuations, and more convenient dosage regimens which may improve medication adherence and treatment outcomes [11] (Table 1)
Proc Natl Acad Sci U S A 96, 1484314847 (1999)
PLoS One 8 (7), e69010
The apical surface of the L-cell faces the gut lumen, where it has direct contact with luminal nutrients (Figure 3) [208]
